This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Case Reports

. 1998 Mar 26;12(5):538.

Resolution of azole-resistant oropharyngeal candidiasis after initiation of potent combination antiretroviral therapy

H Valdez, B M Gripshover, R A Salata, M M Lederman

PMID: 9543458

Case Reports

Resolution of azole-resistant oropharyngeal candidiasis after initiation of potent combination antiretroviral therapy

H Valdez et al. AIDS. 1998.

. 1998 Mar 26;12(5):538.

Authors

H Valdez, B M Gripshover, R A Salata, M M Lederman

PMID: 9543458

No abstract available

PubMed Disclaimer

Similar articles

Reduction in oropharyngeal candidiasis following introduction of protease inhibitors.
Hood S, Bonington A, Evans J, Denning D. Hood S, et al. AIDS. 1998 Mar 5;12(4):447-8. AIDS. 1998. PMID: 9520182 No abstract available.
A randomized study of the use of fluconazole in continuous versus episodic therapy in patients with advanced HIV infection and a history of oropharyngeal candidiasis: AIDS Clinical Trials Group Study 323/Mycoses Study Group Study 40.
Goldman M, Cloud GA, Wade KD, Reboli AC, Fichtenbaum CJ, Hafner R, Sobel JD, Powderly WG, Patterson TF, Wheat LJ, Stein DK, Dismukes WE, Filler SG; AIDS Clinical Trials Group Study Team 323; Mycoses Study Group Study Team 40. Goldman M, et al. Clin Infect Dis. 2005 Nov 15;41(10):1473-80. doi: 10.1086/497373. Epub 2005 Oct 12. Clin Infect Dis. 2005. PMID: 16231260 Clinical Trial.
Withdrawal of fluconazole suppressive therapy for thrush in patients responding to combination antiviral therapy including protease inhibitors.
Gripshover BM, Valdez H, Salata RA, Lederman MM. Gripshover BM, et al. AIDS. 1998 Dec 24;12(18):2513-4. AIDS. 1998. PMID: 9875599 No abstract available.
The diagnosis and treatment of candidiasis: current therapeutic options.
Filler SG. Filler SG. AIDS Patient Care STDS. 1997 Feb;11 Suppl 1:S10-4; discussion S15. AIDS Patient Care STDS. 1997. PMID: 11361745 Review. No abstract available.
[Fluconazole (Diflucan): its clinical spectrum and development].
Espejo Martínez J, Alvarez Medina MP, Sánchez Morales S. Espejo Martínez J, et al. Rev Clin Esp. 1997 Apr;197 Suppl 1:86-93. Rev Clin Esp. 1997. PMID: 9297211 Review. Spanish. No abstract available.

See all similar articles

Cited by

Molecular mechanisms of fluconazole resistance in Candida dubliniensis isolates from human immunodeficiency virus-infected patients with oropharyngeal candidiasis.
Perea S, López-Ribot JL, Wickes BL, Kirkpatrick WR, Dib OP, Bachmann SP, Keller SM, Martinez M, Patterson TF. Perea S, et al. Antimicrob Agents Chemother. 2002 Jun;46(6):1695-703. doi: 10.1128/AAC.46.6.1695-1703.2002. Antimicrob Agents Chemother. 2002. PMID: 12019078 Free PMC article.
Lack of ritonavir antifungal effect in vitro.
Diz P, Ocampo A, Iglesias I, Otero I. Diz P, et al. Antimicrob Agents Chemother. 1999 Apr;43(4):997. doi: 10.1128/AAC.43.4.997. Antimicrob Agents Chemother. 1999. PMID: 10200872 Free PMC article. No abstract available.
Therapy and prophylaxis of opportunistic infections in HIV-infected patients: a guideline by the German and Austrian AIDS societies (DAIG/ÖAG) (AWMF 055/066).
Thoden J, Potthoff A, Bogner JR, Brockmeyer NH, Esser S, Grabmeier-Pfistershammer K, Haas B, Hahn K, Härter G, Hartmann M, Herzmann C, Hutterer J, Jordan AR, Lange C, Mauss S, Meyer-Olson D, Mosthaf F, Oette M, Reuter S, Rieger A, Rosenkranz T, Ruhnke M, Schaaf B, Schwarze S, Stellbrink HJ, Stocker H, Stoehr A, Stoll M, Träder C, Vogel M, Wagner D, Wyen C, Hoffmann C; Deutsche AIDS Gesellschaft; Österreichische AIDS-Gesellschaft. Thoden J, et al. Infection. 2013 Sep;41 Suppl 2(Suppl 2):S91-115. doi: 10.1007/s15010-013-0504-1. Epub 2013 Sep 14. Infection. 2013. PMID: 24037688 Free PMC article.
Immune Reconstitution and the Consequences for Opportunistic Infection Treatment and Prevention.
Powderly WG. Powderly WG. Curr Infect Dis Rep. 1999 Apr;1(1):99-104. doi: 10.1007/s11908-999-0016-4. Curr Infect Dis Rep. 1999. PMID: 11095773
Lopinavir and ritonavir act synergistically with azoles against Candida auris in vitro and in a mouse model of disseminated candidiasis.
Salama EA, Eldesouky HE, Elgammal Y, Abutaleb NS, Seleem MN. Salama EA, et al. Int J Antimicrob Agents. 2023 Sep;62(3):106906. doi: 10.1016/j.ijantimicag.2023.106906. Epub 2023 Jun 29. Int J Antimicrob Agents. 2023. PMID: 37392947 Free PMC article.

See all "Cited by" articles

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Wolters Kluwer
Medical
- MedlinePlus Health Information